Mio Namba, Yuichiro Tsunemi, Makoto Kawashima. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » AgedAntineoplastic Agents/adverse effectsBenzenesulfonates/adverse effectsCarcinoma, Renal Cell/secondaryDrug-Related Side Effects and Adverse Reactions/etiologyErythema Multiforme/chemically inducedErythema Multiforme/pathologyFemaleHumansKidney Neoplasms/pathologyLung Neoplasms/drug therapyLung Neoplasms/secondaryMaleMiddle AgedNiacinamide/analogs & derivativesPhenylurea CompoundsProtein Kinase Inhibitors/adverse effectsPyridines/adverse effectsSorafenib
Substances： See more » Antineoplastic AgentsBenzenesulfonatesPhenylurea CompoundsProtein Kinase InhibitorsPyridinesNiacinamideSorafenib
Year: 2011 PMID： 21926043 DOI： 10.1684/ejd.2011.1535
Source DB: PubMed Journal: Eur J Dermatol ISSN： 1167-1122 Impact factor: 3.328